M2e与Qβ融合原核表达载体的构建与初步评价

Abstract
Figure/Table
References (16)
Related Citation (14)

Download: PDF (0 KB) HTML (36 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To construct a recombinant prokaryotic expression vector of influenza virus M2 gene(M2e)and Qβ,and to conduct immunological evaluation of Qβ-M2e virus-like particles(VLPs),to make a foundation for the development of preventive vaccines.Methods By means of molecular biology,M2e and Qβ plasmid vector were connected to construct a recombinant prokaryotic expression vector,which was identified by restriction enzyme digestion and sequencing.Then,transformed the recombinant plasmids into Escherichia coliBL21,the fusion protein Qβ-M2e was recovered and purified by density gradient centrifugation.After the animals were immunized,the proliferation of germinal center(GC)B cells was detected by immunohistochemistry and flow cytometry.Results The enzyme digestion and sequencing results were consistent with the expected.The fusion protein was observed under the electron microscope as a particle-like protein.After immunizing animals,GC B cells proliferated significantly.Conclusion The recombinant Qβ-M2e vector has been constructed successfully.And the expressed Qβ-M2e virus particles were evaluated by preliminary cytology.The vector might be able to serve as a candidate vector vaccine for influenza virus VLP vaccine,which provides information for further study of general influenza vaccine.

Key words： M2e;Virus-like particles;Q&beta particles;Prokaryotic expression system;Flow cytometry;Immunohistochemistry

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	JING Xin-rui
	XING Ti-kun
	SONG Lu-ping
	YANG Zhen-ping
	WANG Ya-ping
	LIU wei
	SONG Yan-jun
	ZHANG Jing-jing

Cite this article:

JING Xin-rui,XING Ti-kun,SONG Lu-ping, et al. Construction and preliminary evaluation of the fusion prokaryotic expression vector of M2e and Qβ[J]. 中国当代医药, 2021, 28(15): 8-11.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I15/8

[1]	刘亚辉，郭潮潭.甲型流感病毒M2蛋白的研究进展[J].中国医药导报，2017，34（14）：37-39.
[6]	严延生.流感疫苗的研究进展[J].中国人兽共患病学报，2018，3（8）：677-682.
[7]	张静静，王斌，宋路萍，等.基于甲型流感病毒血凝素的广谱流感疫苗研究发展[J].中国当代医药，2018，25（29）：23-25.
[8]	李琼，王凯航，周立志，等.流感病毒M2e与白喉毒素无毒突变体CRM197融合蛋白的抗原性和免疫原性分析[J].病毒学报，2017，33（4）：483-493.
[9]	Janet T，Jaume T.Viroporins in the influenza virus[J].Cell，2019，8（7）：654-674.
[2]	Wohlgemuth N，Lane AP，Pekosz A.Influenza A virus M2 protein apical targeting is required for efficient virus replication[J].J Virol，2018，92（22）：e01425-e01418.
[3]	Daria M，Irina IS，Larisa R，et al.M2e-based universal influenza vaccines：A historical overview and new approaches to development[J].J Biomed Sci，2019，26（1）：76-90.
[4]	Charlton Hume HK，Vidigal J，Carrondo MJT，et al.Synthetic biology for bioengineering virus-like particle vaccines[J].Biotechnol Bioeng，2019，116（4）：919-935.
[5]	Minkner R，Park EY.Purification of virus-like particles（VLPs）expressed in the silkworm bombyx mori[J].Biotechnol Lett，2018，40（4）：659-666.
[10]	Lee YN，Kim MC，Lee YT，et al.Cross protection against influenza A virus by yeast-expressed heterologous tandem repeat M2 extracellular proteins[J].PLos One，2015，10（9）：e0137822.
[11]	Ramirez A，Morris S，Maucourant S，et al.A virus-like particle vaccine candidate for influenza A virus based on multiple conserved antigens presented on hepatitis B tandem core particles[J].Vaccine，2018，36（6）：873-880.
[12]	Mohammad B，Deepali K.Seasonal vaccine in immunocompromised persons[J].Hum Vaccin Immunother，2018，14（6）：1311-1322.
[13]	Corder BN，Bullard BL，DeBeauchamp JL，et al.Influenza H1 mosaic hema-gglutinin vaccine induces broad immunity and protection in mice[J].Vaccine，2019，7（4）：195-212.
[14]	Atsmon J，Caraco Y，Sagit ZS，et al.Priming by a novel universal influe--nza vaccine（Multimeric-001）-A gateway for improving immune response in the elderly population[J].Vaccine，2014，3（44）：5816-5823.
[15]	Durous L，Rosa-Calatrava M，Petiot E.Advances in influenza virus-like particles bioprocesses[J].Vaccine，2019，18（12）：1285-1300.
[16]	Buffin S，Peubez I，Barrière F，et al.Influenza A and B virus-like particles produced in mammalian cells are highly immunogenic and induce functional antibodies[J].Vaccine，2019，37（46）：6857-6867.